Document Detail

Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden.
MedLine Citation:
PMID:  22803699     Owner:  NLM     Status:  Publisher    
Background: Prevalence data on human T-lymphotropic virus types 1 and 2 (HTLV-1/2) in Sweden have not been updated since 1995. The seroprevalence among blood donors at that time was 0.2/10,000. A few years earlier, a high prevalence of HTLV-2 was found in intravenous drug users (IDUs) in Stockholm (3.4%). The objective of this study was to update information on the seroprevalence of HTLV in several study groups. Methods: Serum samples from pregnant women, hepatitis C virus (HCV)-positive individuals, and IDUs in Stockholm were investigated for HTLV-1/2 antibodies. Data from the mandatory HTLV-1/2 screening (2003-2006) of in vitro fertilization (IVF) clients were compiled, as well as data from new blood donors. Results: Eight out of 35,000 IVF patients were positive for anti-HTLV-1/2 (seroprevalence 2.3 per 10,000). Of the anti-HCV-positive individuals (n = 355), 1 sample was HTLV-1-positive (28.2 per 10,000). From 1995 to 2007, 18 HTLV-positive new blood donors were identified out of approximately 550,000 individuals tested (0.3 per 10,000). Thirty-five of 1079 tested IDUs were screening reactive. Conclusions: Since the start of screening in 1994, there has been no increased seroprevalence of HTLV-1/2 among blood donors in Sweden. Seroprevalence among Swedish IVF patients is 10 times higher than among blood donors. This finding is comparable to a 2003 European seroprevalence study of pregnant women in 7 countries. However, the possibility that the IVF group includes individuals with a higher risk of acquiring sexually transmitted infections, including HTLV, than the general population cannot be ruled out.
Kerstin Malm; Bengt Ekermo; Kristina Hillgren; Sven Britton; Hans Fredlund; Sören Andersson
Related Documents :
17316779 - Experimental neosporosis in bulls: parasite detection in semen and blood and specific a...
22706009 - The history of antiretroviral therapy and of its implementation in resource-limited are...
10530439 - Study on microbial persistence in end-stage idiopathic dilated cardiomyopathy.
22738669 - Expression of p16(ink4a) as a biomarker of t-cell aging in hiv-infected patients prior ...
22403269 - Hepatitis c virus infection and kidney disease: a meta-analysis.
18581019 - Comparison of nested-polymerase chain reaction and virus culture for the diagnosis of g...
11106299 - Hiv dementia: the role of the basal ganglia and dopaminergic systems.
23343909 - Incident tuberculosis and risk factors among hiv-infected children in dar es salaam, ta...
25211439 - Temporal trends in mortality among people who use drugs compared with the general dutch...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-17
Journal Detail:
Title:  Scandinavian journal of infectious diseases     Volume:  -     ISSN:  1651-1980     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0215333     Medline TA:  Scand J Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Laboratory Medicine, Örebro University Hospital , Örebro.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Shape-Shifting Micro- and Nanopatterns Controlled by Temperature.
Next Document:  Fluorescence tracking of dissolved and particulate organic matter quality in a river-dominated estua...